Maturation of pulmonary metastases of Wilms' tumor after therapy: a case report.
A case is reported of Wilms' tumor associated with multiple pulmonary metastases histologically showing maturation of the tumor cells at 9 years after the resection of the primary tumor and intensive therapy. A huge tumor of a 22-month-old patient's right kidney was resected. The tumor was diagnosed as Wilms' tumor of mesenchymal type (stage 1), which consisted of predominantly immature mesenchymal tissue including rhabdomyoblasts, smooth muscle and fibrous tissue, and few blastemal and epithelial components. Intensive preoperative and postoperative chemotherapy with actinomycin D and vincristine and postoperative irradiation therapy totaling 16 Gy were carried out. The patient was regularly followed up uneventfully until 9 years after the surgery. On routine chest x ray at the age of 10 years 11 months, multiple pulmonary nodules were found. The excised nodules from the bilateral lungs disclosed similar histology, exclusively composed of dense collagen bundles and fibrocytes intermingled with mature striated muscle bundles. No immature tumor components were detected. The possible effect of intensive therapy in this maturation was stressed, although spontaneous benign differentiation of tumor cells cannot be excluded.
Shimmoto
K
K
Department of Pathology, Jikei University School of Medicine, Tokyo, Japan.
Ushigome
S
S
Nikaido
T
T
Kikuchi
Y
Y
Kobayashi
N
N
Yamazaki
Y
Y
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002454:Cell Differentiation / Q000187:drug effects / Q000528:radiation effects; D002648:Child; D003131:Combined Modality Therapy; D003609:Dactinomycin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000628:therapy; D008175:Lung Neoplasms / Q000473:pathology / Q000556:secondary* / Q000601:surgery; D009392:Nephrectomy; D011878:Radiotherapy; D014750:Vincristine / Q000008:administration & dosage; D009396:Wilms Tumor / Q000473:pathology / Q000556:secondary* / Q000628:therapy
D003609:Dactinomycin; D014750:Vincristine